Occurrence of SARS-CoV-2 infection and seroprevalence of IgM and IgG antibodies in police officers: a cross-sectional study

Ocorrência de infecção SARS-CoV-2 e soroprevalência de anticorpos IgM e IgG em policiais militares: um estudo transver


  • Adriana Gibara Guimarães UFS


exposição ocupacional, epidemiologia, policiais militares, COVID-19


Objective: Considering the seriousness of the covid-19 pandemic and the exposure of workers in essential services, this study aimed to assess the SARS-Cov-2 infection rate and the seroprevalence of IgM and IgG antibodies in military police officers in a city in northeastern Brazil. Methods: This cross-sectional observational study comprised 139 police officers. They completed a brief socio-epidemiological questionnaire, and biological material was collected to carry out RT-PCR and immunofluorescence tests (IgM and IgG). Results: We found that 44.6% had positive RT-PCR, with a seroprevalence of 2.2% and 10.1% for IgM and IgG, respectively. But almost half of those positive were asymptomatic. There was a significant association between the presence of the two antibodies, with OR= 20.7 (p = 0.02). Conclusion: These results reinforce the need for testing and immunization in this category, in order to guarantee the safety of the professionals and those that they assist.


Download data is not yet available.


1. Hu, B., Guo, H., Zhou, P., et al. “Characteristics of SARS-CoV-2 and COVID-19,” Nature Reviews. Microbiology, 2020, pp. 1–14.
2. Gurgel, R. Q., de Sá, L. C., Souza, D. R. V., et al. “SARS-CoV-2 has been circulating in northeastern Brazil since February 2020: evidence for antibody detection in asymptomatic patients,” The Journal of Infection, V. 82, No. 5, 2021, pp. 186–230.
3. WHO. “WHO Coronavirus (COVID-19) Dashboard | WHO Coronavirus (COVID-19) Dashboard With Vaccination Data.” Available at: https://covid19.who.int/table. Accessed June 15, 2021.
4. Reupert, A. “Change and (the need for) adaptability: the new normal,” Advances in Mental Health, V. 18, No. 2, 2020, pp. 91–3.
5. Sigahi, T. F. A. C., Kawasaki, B. C., Bolis, I., et al. “A systematic review on the impacts of Covid‐19 on work: Contributions and a path forward from the perspectives of ergonomics and psychodynamics of work,” Human Factors and Ergonomics in Manufacturing, 2021.
6. Gaitens, J., Condon, M., Fernandes, E., et al. “COVID-19 and Essential Workers: A Narrative Review of Health Outcomes and Moral Injury,” International Journal of Environmental Research and Public Health, V. 18, No. 4, 2021.
7. Melo, M. S. de., Borges, L. P., Souza, D. R. V. de., et al. “Anti-SARS-CoV-2 IgM and IgG antibodies in health workers in Sergipe, Brazil,” medRxiv, 2020, p. 2020.09.24.20200873.
8. Borges, L. P., Martins, A. F., de Melo, M. S., et al. “Seroprevalence of SARS-CoV-2 IgM and IgG antibodies in an asymptomatic population in Sergipe, Brazil,” Revista Panamericana de Salud Pública, V. 44, 2020.
9. Violanti, J. M., Fekedulegn, D., Hartley, T. A., et al. “Highly Rated and most Frequent Stressors among Police Officers: Gender Differences,” American journal of criminal justice : AJCJ, V. 41, No. 4, 2016, pp. 645–62.
10. Santos de Melo, M., Pinto Borges, L., Valadão de Souza, D. R., et al. “Strategies for containing an emerging COVID-19 pandemic in a population: an epidemiological survey,” Trends in Research, V. 3, No. 4, 2020.
11. Padhye, N. S. “Reconstructed diagnostic sensitivity and specificity of the RT-PCR test for COVID-19,” medRxiv, 2021, p. 2020.04.24.20078949.
12. WHO. “Criteria for releasing COVID-19 patients from isolation.” Available at: https://www.who.int/news-room/commentaries/detail/criteria-for-releasing-covid-19-patients-from-isolation. Accessed June 14, 2021.
13. Wilmes, P., Zimmer, J., Schulz, J., et al. “SARS-CoV-2 transmission risk from asymptomatic carriers: Results from a mass screening programme in Luxembourg,” The Lancet Regional Health – Europe, V. 4, 2021.
14. Oran, D. P., and Topol, E. J. “Prevalence of Asymptomatic SARS-CoV-2 Infection,” Annals of Internal Medicine, 2020.
15. Zhang, J., Zhang, X., Liu, J., et al. “Serological detection of 2019-nCoV respond to the epidemic: A useful complement to nucleic acid testing,” International Immunopharmacology, V. 88, 2020, p. 106861.
16. Long, Q.-X., Liu, B.-Z., Deng, H.-J., et al. “Antibody responses to SARS-CoV-2 in patients with COVID-19,” Nature Medicine, V. 26, No. 6, 2020, pp. 845–8.
17. Bonifácio, L. P., Pereira, A. P. S., Araújo, D. C. de A. E., et al. “Are SARS-CoV-2 reinfection and Covid-19 recurrence possible? a case report from Brazil,” Revista Da Sociedade Brasileira De Medicina Tropical, V. 53, 2020, p. e20200619.